Collegium Pharmaceutical
COLL
COLL
101 hedge funds and large institutions have $526M invested in Collegium Pharmaceutical in 2017 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 39 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
35% more funds holding
Funds holding: 75 → 101 (+26)
0.53% less ownership
Funds ownership: 88.06% → 87.53% (-0.53%)
53% less call options, than puts
Call options by funds: $622K | Put options by funds: $1.34M
Holders
101
Holding in Top 10
2
Calls
$622K
Puts
$1.34M
Top Buyers
| 1 | +$60.8M | |
| 2 | +$8.61M | |
| 3 | +$8.49M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.17M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.43M |
Top Sellers
| 1 | -$21.6M | |
| 2 | -$20.4M | |
| 3 | -$13.3M | |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$5.96M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$5.48M |